Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (377)

1

Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults : A phase 3, randomized, active-controlled, multicenter trial

enthalten in: Vaccine | 2024

von Nurdin, A. | Movieta Nency, Y. | Maddeppungeng, M. | +24

2

Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants ≥ 2 and < 43 months of Age : A phase III, multicenter, active controlled, assessor-blinded, randomized, parallel-group study

enthalten in: Vaccine | 2024

von Nakano, T. | Hasegawa, M. | Endo, M. | +2

3

Contrast-enhanced Ultrasound Using Intradermal Microbubble Sulfur Hexafluoride in Non-invasive Axillary Staging in Breast Cancer : Are we Missing a Chance?

enthalten in: Anticancer research | 2024

von Vanni, G. | Materazzo, M. | Lorenzo, N. | +9

4

Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma : findings from the phase III ClarIDHy study

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Fan, B. | Abou-Alfa, G. | Zhu, A. | +7

5

Factors affecting responsiveness of vadadustat in patients with anemia associated with chronic kidney disease : a post-hoc subgroup analysis of Japanese phase 3 randomized studies

enthalten in: Clinical and experimental nephrology | 2024

von Nangaku, M. | Ueta, K. | Nishimura, K. | +2

6

Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed : LIBERTY 3-Year Study

enthalten in: Neurology | 2024

von Reuter, U. | Goadsby, P. | Ferrari, M. | +9

7

Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD : a multicentre, randomized trial

enthalten in: BMC medicine | 2024

von Wang, Y. | Liu, Q. | Wu, D. | +14

8

Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis : Findings from the Pivotal OPTIMUM Study

enthalten in: Journal of women's health (2002) | 2024

von Jones, R. | Turkoz, I. | Ait-Tihyaty, M. | +3

9

Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies

enthalten in: Journal of Crohn's & colitis | 2024

von Verstockt, B. | Pivorunas, V. | Al Mahi, N. | +10

10

Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy : a randomized phase 3 ASTRAL-2 trial

enthalten in: Blood advances | 2024

von Roboz, G. | Sanz, G. | Griffiths, E. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[38]